Recent progress in therapeutic drug delivery systems for treatment of traumatic CNS injuries

Bikram Khadka, Jae Young Lee, Ki Taek Kim, Jong Sup Bae

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations

Abstract

Most therapeutics for the treatment of traumatic central nervous system injuries, such as traumatic brain injury and spinal cord injury, encounter various obstacles in reaching the target tissue and exerting pharmacological effects, including physiological barriers like the blood-brain barrier and blood-spinal cord barrier, instability rapid elimination from the injured tissue or cerebrospinal fluid and off-target toxicity. For central nervous system delivery, nano- and microdrug delivery systems are regarded as the most suitable and promising carriers. In this review, the pathophysiology and biomarkers of traumatic central nervous system injuries (traumatic brain injury and spinal cord injury) are introduced. Furthermore, various drug delivery systems, novel combinatorial therapies and advanced therapies for the treatment of traumatic brain injury and spinal cord injury are emphasized.

Original languageEnglish
Pages (from-to)1759-1778
Number of pages20
JournalFuture Medicinal Chemistry
Volume12
Issue number19
DOIs
StatePublished - Oct 2020

Keywords

  • combinatorial therapies
  • drug delivery systems
  • local and systemic administration
  • neuronal regeneration
  • primary and secondary injuries
  • spinal cord injury
  • traumatic brain injury

Fingerprint

Dive into the research topics of 'Recent progress in therapeutic drug delivery systems for treatment of traumatic CNS injuries'. Together they form a unique fingerprint.

Cite this